- Home
- ALRN vs CEV Comparison
ALRN vs CEV Comparison
Compare ALRN & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- CEV
- Stock Information
- Founded
- ALRN 2001
- CEV 1999
- Country
- ALRN United States
- CEV United States
- Employees
- ALRN N/A
- CEV N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- CEV Finance/Investors Services
- Sector
- ALRN Health Care
- CEV Finance
- Exchange
- ALRN Nasdaq
- CEV Nasdaq
- Market Cap
- ALRN 76.9M
- CEV 75.9M
- IPO Year
- ALRN 2017
- CEV N/A
- Fundamental
- Price
- ALRN $3.42
- CEV $10.41
- Analyst Decision
- ALRN Strong Buy
- CEV
- Analyst Count
- ALRN 1
- CEV 0
- Target Price
- ALRN $19.00
- CEV N/A
- AVG Volume (30 Days)
- ALRN 93.8K
- CEV 19.6K
- Earning Date
- ALRN 11-26-2024
- CEV 01-01-0001
- Dividend Yield
- ALRN N/A
- CEV 4.23%
- EPS Growth
- ALRN N/A
- CEV N/A
- EPS
- ALRN N/A
- CEV 0.36
- Revenue
- ALRN N/A
- CEV N/A
- Revenue This Year
- ALRN N/A
- CEV N/A
- Revenue Next Year
- ALRN N/A
- CEV N/A
- P/E Ratio
- ALRN N/A
- CEV $29.36
- Revenue Growth
- ALRN N/A
- CEV N/A
- 52 Week Low
- ALRN $1.57
- CEV $8.83
- 52 Week High
- ALRN $7.42
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- ALRN 47.41
- CEV 33.56
- Support Level
- ALRN $3.37
- CEV $10.42
- Resistance Level
- ALRN $3.92
- CEV $10.67
- Average True Range (ATR)
- ALRN 0.35
- CEV 0.09
- MACD
- ALRN -0.06
- CEV -0.00
- Stochastic Oscillator
- ALRN 21.36
- CEV 0.00
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.